Target intelligence / Profile preview

TPTE2 pseudogene 2 (TPTE2P2)

Target: TPTE2P2
Molecular classification: Other

Overview

TPTE2 pseudogene 2 (TPTE2P2) is classified as a pseudogene, not a protein-coding gene or a functional therapeutic target. Pseudogenes are genomic DNA sequences similar to normal genes but are nonfunctional; they typically do not encode proteins or perform biological roles. TPTE2P2 is related by sequence to TPTE2, which encodes a membrane-associated lipid phosphatase, but TPTE2P2 itself does not have a known function, molecular activity, or therapeutic relevance[5]. No disease association, drug interaction, or known biological function has been described for TPTE2P2 in the available literature.

Other names: TPTE2P2

Beyond the preview

Go deeper on TPTE2 pseudogene 2 (TPTE2P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TPTE2 pseudogene 2 (TPTE2P2).

Explore the full profile